Page 11 - GPD-4-1

Gene & Protein in Disease Identification of new genes

13. Chen Q, Liu Y, Gao Y, et al. A comprehensive genomic and doi: 10.1038/nrc3589
transcriptomic dataset of triple-negative breast cancers. Sci 17. Parvez S, Brandt ZJ, Peterson RT. Large-scale F0
Data. 2022;9:587.
CRISPR screens in vivo using MIC-Drop. Nat Protoc.
doi: 10.1038/s41597-022-01681-z 2023;18:1841-1865.
14. Nagasawa S, Kuze Y, Maeda I, et al. Genomic profiling doi: 10.1038/s41596-023-00821-y
reveals heterogeneous populations of ductal carcinoma 18. Li A, Chapuy B, Varelas X, Sebastiani P, Monti S.
in situ of the breast. Commun Biol. 2021;4:438.
Identification of candidate cancer drivers by integrative
doi: 10.1038/s42003-021-01959-9 Epi-DNA and Gene Expression (iEDGE) data analysis. Sci
Rep. 2019;9:16904.
15. Grassmann F, Pawitan Y, Czene K. A systems genomics
approach to uncover the molecular properties of cancer doi: 10.1038/s41598-019-52886-z
genes. Sci Rep. 2020;10:18392.
19. López-Cortés A, Paz-y-Miño C, Guerrero S, et al.
doi: 10.1038/s41598-020-75400-2 OncoOmics approaches to reveal essential genes in breast
cancer: A panoramic view from pathogenesis to precision
16. White R, Rose K, Zon L. Zebrafish cancer: The state of
the art and the path forward. Nat Rev Cancer. 2013;13: medicine. Sci Rep. 2020;10:5285.
624-636. doi: 10.1038/s41598-020-62279-2

Volume 4 Issue 1 (2025) 3 doi: 10.36922/gpd.2892